TELLUS THERAPEUTICS
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. It was founded in 2018 and is based in Hillsborough, North Carolina.
TELLUS THERAPEUTICS
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Hillsborough, North Carolina, United States
Country:
United States
Website Url:
http://www.tellustherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
919-491-4995
Total Funding:
53.5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API Google Tag Manager WordPress Google Analytics Google Maps Font Awesome Global Site Tag
Similar Organizations
Aardvark Therapeutics
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Advisors List
Advisor
2020-06-01
Board_member
2022-12-01
Board_member
2022-12-01
Current Employees Featured
Jason Kralic Co-founder & CEO @ Tellus Therapeutics
Co-founder & CEO
Founder
Investors List
Xontogeny
Xontogeny investment in Series A - Tellus Therapeutics
One North Carolina Small Business Program
One North Carolina Small Business Program investment in Grant - Tellus Therapeutics
Xontogeny
Xontogeny investment in Seed Round - Tellus Therapeutics
MassChallenge
MassChallenge investment in Non Equity Assistance - Tellus Therapeutics
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Debt Financing - Tellus Therapeutics
MassChallenge
MassChallenge investment in Grant - Tellus Therapeutics
Official Site Inspections
http://www.tellustherapeutics.com
- Host name: 149.113.180.107.host.secureserver.net
- IP address: 107.180.113.149
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260

More informations about "Tellus Therapeutics"
About – Tellus Therapeutics
Jason Kralic, Ph.D., CEO and Co-founder Jason co-founded Tellus with Dr. Benner, and is a neuropharmacologist and life sciences business development executive with broad experience …See details»
Tellus Therapeutics
Tellus Therapeutics is a neonatal care company developing treatments for our most vulnerable patient populationSee details»
Tellus Therapeutics Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Tellus Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Tellus Therapeutics - Crunchbase Company Profile
TT-20: A small molecule derived from human maternal breast milk, currently in late-stage pre-clinical development, aimed at treating white matter injury …See details»
About OG – Tellus Therapeutics
Simon Gregory, Ph.D., Scientific Co-Founder and Scientific Advisory Board Member, is a Professor in the Department of Neurology, Duke University School of Medicine, and Research Director of the Duke Center for Research in …See details»
Tellus Therapeutics Executive Summary - National Institute of ...
Www.tellustherapeutics.com Dr. Jason Kralic PhD | jasonkralic@tellustherapeutics.com | 919-491-4995 | Durham, North Carolina | 2 employees Company Profile Tellus Therapeutics was …See details»
Tellus Therapeutics, Inc. Company Profile | Hillsborough, NC ...
Find company research, competitor information, contact details & financial data for Tellus Therapeutics, Inc. of Hillsborough, NC. Get the latest business insights from Dun & Bradstreet.See details»
Tellus Therapeutics Company Profile | Management and
Tellus Therapeutics Profile and History . As a preclinical stage life sciences start-up company, Tellus is focused on planning, funding and executing development programs to demonstrate …See details»
Tellus Therapeutics, Inc - LinkedIn
Tellus Therapeutics, Inc was thrilled to participate in the Alexandria Center® for Advanced Technologies (ACAT) Member Symposium. Our team, including Jason Kralic and Lilia Koza, …See details»
Tellus Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Www.tellustherapeutics.com. Startups | Holding Company | 2018 | North Carolina, United States | < 10 | www.tellustherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. ... The …See details»
Tellus Therapeutics - Products, Competitors, Financials, Employees ...
Tellustherapeutics.com. Overview & Products; Financials; People; Founded Year 2018. Stage Series A | Alive. Total Raised $37.88M. Last Raised $35M | 2 yrs ago. About Tellus …See details»
Tellus Therapeutics - Overview, News & Similar companies
Dec 12, 2022 View Tellus Therapeutics (www.tellustherapeutics.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well …See details»
Tellus Therapeutics, Inc Information - RocketReach
Tellustherapeutics.com; 1 919684XXXX; View Similar People. Related Companies Total Exposure Designs. 10 $6m Flexcell International Corporation. 8 $5m TriClean, Inc. 9 $5.8m Beau …See details»
Tellus Therapeutics Inc. | North Carolina Biotech Center
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain and gut injuries.See details»
Tellus Therapeutics to develop first treatment for newborns with …
May 12, 2021 Tellus’ goal for its lead asset (TT-20) is to provide a treatment for every baby born at risk for brain injury and improve neurodevelopmental outcomes for affected children. For …See details»
Tellus Therapeutics - VentureRadar
Website: http://www.tellustherapeutics.com/ Develops interventions for newborns' unmet needs, utilizing compounds in breast milk to regenerate myelin and repair brain ...See details»
Tellus Therapeutics Inc Overview - Salary.com
Discover essential details about Tellus Therapeutics Inc, including address, contact, and journey of our company's evolution.See details»
Tellus Therapeutics Company Profile -Sales, Contacts, Competitors ...
Tellus Therapeutics is in the Pharmaceutical Preparations industry within the Chemicals and Allied Products sector and has been in business for approximately 6 years.See details»
R & D – Tellus Therapeutics
Neonatal white matter injury (WMI) is the leading cause of neurodevelopmental disability in survivors of preterm birth. Neurodevelopmental disability includes motor, cognitive and …See details»
Tellus Therapeutics Secures Seed Financing to Develop the First ...
May 12, 2021 jasonkralic@tellustherapeutics.com. Media: Katie Gallagher LaVoie Health Science kgallagher@lavoiehealthscience.com +1 617-792-3937. Katherine Marriott LaVoie …See details»